Praxis Precision Medicines (PRAX) Change in Account Payables (2019 - 2026)

Praxis Precision Medicines' Change in Account Payables history runs 8 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 37.1% year-over-year to $6.5 million; the TTM figure through Mar 2026 stood at $8.2 million (down 38.94% YoY), while the FY2025 annual figure was $12.1 million, up 80.2% from the prior year.
• Change in Account Payables was $6.5 million for Q1 2026 at Praxis Precision Medicines, up from -$6.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $10.4 million in Q1 2025 to a low of -$9.0 million in Q2 2023.
• Historically, Change in Account Payables has averaged $1.2 million across 5 years, with a median of $2.0 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Change in Account Payables sank 626.01% in 2022, then soared 883.67% in 2024.
• A 5-year view of Change in Account Payables shows it stood at $4.6 million in 2022, then plunged by 128.55% to -$1.3 million in 2023, then sank by 91.07% to -$2.5 million in 2024, then sank by 149.56% to -$6.2 million in 2025, then surged by 205.42% to $6.5 million in 2026.
• The last three Change in Account Payables figures came in at $6.5 million (Q1 2026), -$6.2 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.